Click here for a live version of this chart.
The Biotech ETF has had a devil of a time getting above 92 this year. Right now it is trying again. The low volume numbers don't bode well but remember that ETF volume data can be tricky to interpret. A close above 92 would do wonders for this chart. Time will tell - as always.
The Nifty continues to be range-bound, oscillating in a narrow 476.65-point range. Will the index break above its resistance level? Milan Vaishnav shares his thoughts.... READ MORE
The S&P 500 ($SPX) and Nasdaq Composite ($COMPQ) have spent the entire week in the red, falling every trading day. Throughout the selloff, though, the Cboe Volatility Index ($VIX) has stayed below 20, which suggests that investors aren’t panicking. This could have something to do with timing.... READ MORE
With the major indexes under pressure, strength is quietly emerging in places many investors may not be watching. Mary Ellen McGonagle reveals where buyers are stepping in, what areas are showing renewed momentum, and what those moves could signal for the market in the weeks ahead.... READ MORE
Bearish RSI divergences are appearing across market leaders from semiconductors to financials. Dave Keller, CMT, explains how weakening momentum can signal a change of character, what confirms a true trend reversal, and why RSI remains a critical tool for monitoring market leadership.... READ MORE
AI stocks have been soaring, but does it mean AI stocks are in a bubble? Tom Bowley analyzes charts of five semiconductor companies before unpacking them further in a Livestream event.... READ MORE
While technology stocks sell off, other sectors are seeing investor interest and some industry groups are hitting new highs. Arthur Hill analyzes these sectors and groups and discusses why they have the potential to move higher.... READ MORE